Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 78

1.

Vitamin d and stage 5 chronic kidney disease: a new paradigm?

Heaf JG, Joffe P, Marckmann P.

Semin Dial. 2012 Jan-Feb;25(1):50-8. doi: 10.1111/j.1525-139X.2011.00986.x. Epub 2011 Oct 4. Review.

PMID:
21967444
[PubMed - indexed for MEDLINE]
3.

Absence of adynamic bone disease in African-Americans with CKD stage 5 after 3 years of vitamin D therapy guided by iPTH and the PTH-(1-84)/N-terminally truncated PTH fragments ratio.

Fehmi H, Osman Y, Bhat S, Nguyen K, Daramola O, Cantor T, Monier-Faugere MC, Yee J, Malluche HH.

Clin Nephrol. 2009 Mar;71(3):267-75.

PMID:
19281737
[PubMed - indexed for MEDLINE]
4.

Effect of depot oral cholecalciferol treatment on secondary hyperparathyroidism in stage 3 and stage 4 chronic kidney diseases patients.

Dogan E, Erkoc R, Sayarlioglu H, Soyoral Y, Dulger H.

Ren Fail. 2008;30(4):407-10. doi: 10.1080/08860220801964210.

PMID:
18569914
[PubMed - indexed for MEDLINE]
5.

Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.

Brown AJ, Slatopolsky E.

Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):134-44. Review.

PMID:
17237840
[PubMed - indexed for MEDLINE]
6.

Beyond minerals and parathyroid hormone: role of active vitamin D in end-stage renal disease.

Wolf M, Thadhani R.

Semin Dial. 2005 Jul-Aug;18(4):302-6. Review. Erratum in: Semin Dial. 2007 Jan-Feb;20(1):table of contents.

PMID:
16076353
[PubMed - indexed for MEDLINE]
7.

The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis.

Raggi P, Chertow GM, Torres PU, Csiky B, Naso A, Nossuli K, Moustafa M, Goodman WG, Lopez N, Downey G, Dehmel B, Floege J; ADVANCE Study Group.

Nephrol Dial Transplant. 2011 Apr;26(4):1327-39. doi: 10.1093/ndt/gfq725. Epub 2010 Dec 8.

PMID:
21148030
[PubMed - indexed for MEDLINE]
Free Article
8.

[Prevention and treatment of renal osteodystrophy: present and future].

Fernández E, Craver L.

Nefrologia. 2006;26 Suppl 3:19-27. Review. Spanish. No abstract available.

PMID:
17469423
[PubMed - indexed for MEDLINE]
9.

Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism.

Cozzolino M, Brancaccio D.

Expert Opin Pharmacother. 2008 Apr;9(6):947-54. doi: 10.1517/14656566.9.6.947. Review.

PMID:
18377338
[PubMed - indexed for MEDLINE]
10.

Control of secondary hyperparathyroidism by vitamin D receptor agonists in chronic kidney disease.

Sprague SM, Coyne D.

Clin J Am Soc Nephrol. 2010 Mar;5(3):512-8. doi: 10.2215/CJN.03850609. Epub 2010 Feb 4. Review.

PMID:
20133492
[PubMed - indexed for MEDLINE]
Free Article
11.

Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure.

Cozzolino M, Gallieni M, Brancaccio D, Arcidiacono T, Bianchi G, Vezzoli G.

J Nephrol. 2006 Sep-Oct;19(5):566-77. Review.

PMID:
17136683
[PubMed - indexed for MEDLINE]
12.

When is Vitamin D contraindicated in dialysis patients?

Evenepoel P.

Semin Dial. 2009 May-Jun;22(3):242-4. doi: 10.1111/j.1525-139X.2009.00564.x. Review. No abstract available.

PMID:
19572999
[PubMed - indexed for MEDLINE]
13.

[Renal osteodystrophy (3); its treatment in dialysis patients].

Ghitu S, Oprisiu R, Benamar L, Said S, Tataru Albu A, Arsenescu I, el Esper N, Morinière P, Fournier A.

Nephrologie. 2000;21(8):413-24. Review. French.

PMID:
11213385
[PubMed - indexed for MEDLINE]
14.

Vitamin D receptor activator selectivity in the treatment of secondary hyperparathyroidism: understanding the differences among therapies.

Brancaccio D, Bommer J, Coyne D.

Drugs. 2007;67(14):1981-98. Review. Erratum in: Drugs. 2007;67(17):2556.

PMID:
17883283
[PubMed - indexed for MEDLINE]
15.

Prevention and treatment of renal osteodystrophy in children with chronic renal insufficiency and end-stage renal disease.

Sanchez CP.

Semin Nephrol. 2001 Sep;21(5):441-50. Review.

PMID:
11559885
[PubMed - indexed for MEDLINE]
16.

Vitamin D treatment in chronic kidney disease.

Andress DL.

Semin Dial. 2005 Jul-Aug;18(4):315-21. Review.

PMID:
16076355
[PubMed - indexed for MEDLINE]
17.

Medical management of secondary hyperparathyroidism in chronic renal failure.

Goodman WG.

Nephrol Dial Transplant. 2003 Jun;18 Suppl 3:iii2-8. Review.

PMID:
12771290
[PubMed - indexed for MEDLINE]
Free Article
18.

Meta-analysis: vitamin D compounds in chronic kidney disease.

Palmer SC, McGregor DO, Macaskill P, Craig JC, Elder GJ, Strippoli GF.

Ann Intern Med. 2007 Dec 18;147(12):840-53.

PMID:
18087055
[PubMed - indexed for MEDLINE]
19.

The role of vitamin D in vascular calcification in chronic kidney disease.

Wolisi GO, Moe SM.

Semin Dial. 2005 Jul-Aug;18(4):307-14. Review.

PMID:
16076354
[PubMed - indexed for MEDLINE]
20.

Effect of vitamin C on parathyroid hormone in hemodialysis patients with mild to moderate secondary hyperparathyroidism.

Sanadgol H, Bayani M, Mohammadi M, Bayani B, Mashhadi MA.

Iran J Kidney Dis. 2011 Nov;5(6):410-5.

PMID:
22057074
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk